Loading
Latest filing published 16 Sept 2026 for Ange Prostatype Genomics AB. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
All filings by Liljeblad & Co Aktiebolag on record concern Ange Prostatype Genomics AB. The record holds 2 filings, all for trades on 15 September 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 16 September 2026 came the latest disclosure, a transaction in Ange Prostatype Genomics AB. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations